The Lancet: Cardiovascular Disease 2012

Clinical Series

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology, Ailments & Diseases, Diseases
Cover of the book The Lancet: Cardiovascular Disease 2012 by The Lancet, Elsevier Health Sciences
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: The Lancet ISBN: 9781455758548
Publisher: Elsevier Health Sciences Publication: August 24, 2012
Imprint: The Lancet Language: English
Author: The Lancet
ISBN: 9781455758548
Publisher: Elsevier Health Sciences
Publication: August 24, 2012
Imprint: The Lancet
Language: English
This book, featuring content from the Aug 11, 2012, issue of The Lancet, has been released to coincide with the European Society of Cardiology (ESC) meeting in Munich, Germany, which is to be held on Aug 25–29, 2012. The Lancet is strongly supportive of cardiology as can be seen from the substantial relevant content in this compilation. In 2011, The Lancet published more papers in this specialty than any other: cardiovascular research contributed about one in four of all published research papers. Featured within are three research articles on lipids and cardiovascular disease which provide balance on the role of high density lipoproteins in cardiovascular disease, and on statins in prevention of cardiac events. There are also three commissioned reviews being presented at the joint ESC–The Lancet session at the Munich meeting that are focused on hypertension. It is estimated that some 40% of the adult population around the world will have high blood pressure, and it is well established that hypertension is strongly associated with other cardiovascular outcomes. Hypertension is by no means a problem only in high-income countries—one of the reviews reports on the prevalence of high blood pressure in low-income and middle-income countries, and on specific health problems and solutions in these countries. The interrelation between hypertension and diabetes (another disease that is rapidly becoming more prevalent) is examined in a second review. In light of the high prevalence and subsequent outcomes it is important to be able to treat hypertension effectively, and the third review discusses drugs and devices that have recently reached the market or are in development. These reviews have been commissioned with the advice and help of Lars H Lindholm.
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
This book, featuring content from the Aug 11, 2012, issue of The Lancet, has been released to coincide with the European Society of Cardiology (ESC) meeting in Munich, Germany, which is to be held on Aug 25–29, 2012. The Lancet is strongly supportive of cardiology as can be seen from the substantial relevant content in this compilation. In 2011, The Lancet published more papers in this specialty than any other: cardiovascular research contributed about one in four of all published research papers. Featured within are three research articles on lipids and cardiovascular disease which provide balance on the role of high density lipoproteins in cardiovascular disease, and on statins in prevention of cardiac events. There are also three commissioned reviews being presented at the joint ESC–The Lancet session at the Munich meeting that are focused on hypertension. It is estimated that some 40% of the adult population around the world will have high blood pressure, and it is well established that hypertension is strongly associated with other cardiovascular outcomes. Hypertension is by no means a problem only in high-income countries—one of the reviews reports on the prevalence of high blood pressure in low-income and middle-income countries, and on specific health problems and solutions in these countries. The interrelation between hypertension and diabetes (another disease that is rapidly becoming more prevalent) is examined in a second review. In light of the high prevalence and subsequent outcomes it is important to be able to treat hypertension effectively, and the third review discusses drugs and devices that have recently reached the market or are in development. These reviews have been commissioned with the advice and help of Lars H Lindholm.

More books from Elsevier Health Sciences

Cover of the book Cardiac Resynchronization Therapy: State of the Art, An Issue of Heart Failure Clinics, E-Book by The Lancet
Cover of the book Hematopathology E-Book by The Lancet
Cover of the book Ethics in Sports Medicine, An Issue of Clinics in Sports Medicine, E-Book by The Lancet
Cover of the book Techniques in Facial Plastic Surgery: Discussion and Debate, Part II, An Issue of Facial Plastic Surgery Clinics, E-Book by The Lancet
Cover of the book Comprehensive Cytopathology E-Book by The Lancet
Cover of the book Atlas of Ultrasound-Guided Regional Anesthesia E-Book by The Lancet
Cover of the book Gastrointestinal Pathology: Classification, Diagnosis, Emerging Entities, An Issue of Surgical Pathology Clinics, E-Book by The Lancet
Cover of the book Exotic Animal Training and Learning, An Issue of Veterinary Clinics: Exotic Animal Practice by The Lancet
Cover of the book Heart Failure in Adult Congenital Heart Disease, An Issue of Heart Failure Clinics, E-Book by The Lancet
Cover of the book Advances in Surgery, E-Book 2012 by The Lancet
Cover of the book Chinese Herbal Formulas: Treatment Principles and Composition Strategies E-Book by The Lancet
Cover of the book Hematology, An Issue of Veterinary Clinics of North America: Exotic Animal Practice, E-Book by The Lancet
Cover of the book Interpretación fácil de la bioestadística by The Lancet
Cover of the book Biologie Anatomie Physiologie by The Lancet
Cover of the book ICD-10-CM/PCS Coding: Theory and Practice, 2015 Edition - E-Book by The Lancet
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy